Kestra Medical CEO sells shares to cover taxes
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Kestra Medical Technologies, Ltd.'s President and Chief Executive Officer, Brian Daniel Webster, reported selling 51,900 common shares of KMTS on August 4, 2026, across three sale transactions. Footnotes state these were nondiscretionary sell-to-cover sales to satisfy tax withholding obligations from restricted stock unit vesting, including 48,625 shares at a weighted average price of $24.4692 per share.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Shares F1, F2 | 48,625 | $24.4692 | $1.19M |
| Sale | Common Shares F1, F3 | 2,833 | $25.1635 | $71K |
| Sale | Common Shares F1, F4 | 442 | $25.9835 | $11K |
Footnotes (4)
- F1. The sale reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the reporting person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units.
- F2. The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $23.9000 to $24.8850. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range.
- F3. The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $24.9500 to $25.9300. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range.
- F4. The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $25.9500 to $26.0300. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range.
Key Figures
Key Terms
sell to cover financial
restricted stock units financial
weighted average price financial
tax withholding obligations financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Kestra Medical Technologies (KMTS) report in this Form 4?
What positions does Brian Daniel Webster hold at Kestra Medical Technologies (KMTS)?
AI-generated analysis. How Rhea-AI works. Not financial advice.